Europe Corneal Transplantation Market Outlook and Strategic Insights by 2028

Europe Corneal Transplantation Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Penetrating Keratoplasty, Descemet Membrane Endothelial Keratoplasty (DMEK), Descemet Stripping Endothelial Keratoplasty (DSEK), Corneal Limbal Stem Cell Transplant, and Others), Indication (Fungal Corneal Ulcer, Fuchs Dystrophy, Keratoconus, Keratitis, and Others), and End User (Hospitals, Eye Clinic, and Ambulatory Surgical Centers)

  • Report Date : May 2022
  • Report Code : TIPRE00029252
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 111

The Europe corneal transplantation market is expected to grow from US$ 110.87 million in 2021 to US$ 160.88 million by 2028; it is estimated to grow at a CAGR of 5.5% from 2021 to 2028.

European countries are experiencing a significant increase in the geriatric patient population, especially those with an age greater than 80. As per the UN Population Aging 2019 report, the number of people aged 80 or above nearly tripled from 1990 to 2019 in the world. As the geriatric population increases, the demands for healthcare services required for this group also continue to grow. The aging of an ocular surface and corneal tissues, and the consequent impairment of visual functions lead to severe eye diseases and significantly impact vision. The conditions that affect these vital parts of the eye place a critical medical and socioeconomic burden on society. Corneal transplantation is a part of keratoplasty procedures, such as endothelial keratoplasty and penetrating keratoplasty. The geriatric population is highly susceptible to Fuchs' dystrophy, a condition treated by endothelial keratoplasty (EK). In addition, bullous keratopathy occurs in older adults undergoing cataract surgeries, such as EK. Thus, the increase in the population of elderlies is driving the overall growth of the Europe corneal transplant market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe corneal transplantation market. The Europe corneal transplantation market is expected to grow at a good CAGR during the forecast period. 

Europe Corneal Transplantation Market Revenue and Forecast to 2028 (US$ Million)

Europe Corneal Transplantation Market Revenue and Forecast to 2028 (US$ Million)
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Europe Corneal Transplantation Market Segmentation 

The Europe corneal transplantation market is segmented based on type, indication, end user, and country. Based on type, the Europe corneal transplantation market is segmented into penetrating keratoplasty, descemet membrane endothelial keratoplasty (DMEK), descemet stripping endothelial keratoplasty (DSEK), corneal limbal stem cell transplant, and others. The penetrating keratoplasty segment dominated the Europe corneal transplantation market in 2020 and descemet membrane endothelial keratoplasty (DMEK) segment is expected to be fastest growing during forecast period. Based on indication, the Europe corneal transplantation market is segmented into fungal corneal ulcer, Fuchs dystrophy, keratoconus, keratitis, and others. The Fuchs dystrophy segment dominated the Europe corneal transplantation market in 2020 and same segment is expected to be fastest growing during forecast period. Based on end user, the Europe corneal transplantation market is segmented into hospitals, eye clinic, and ambulatory surgical centers. The hospitals segment dominated the Europe corneal transplantation market in 2020 and ambulatory surgical centers segment is expected to be fastest growing during forecast period. Based on country, the Europe corneal transplantation market has been segmented into the UK, Germany, France, Italy, Spain, and rest of Europe. Alcon Inc.; Aurolab; Cornea Biosciences, Inc.; Corneat Vision; Florida Lions Eye Bank; Keramed, Inc.; and Lifeline Scientific, Inc. are among the leading companies in the Europe corneal transplantation market.

 
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Corneal transplantation Market – By Type

1.3.2 Europe Corneal transplantation Market – By Indication

1.3.3 Europe Corneal transplantation Market – By End User

1.3.4 Europe Corneal transplantation Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Corneal Transplantation Market – Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

4.3 Experts Opinion

5. Europe Corneal Transplantation Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Incidence of Eye Diseases

5.1.2 Increasing Geriatric Population

5.2 Market Restraints

5.2.1 Risks Associated with Corneal Transplantation and Shortage of Donor Corneas

5.3 Market Opportunities

5.3.1 Growing Use of High-Tech Products for Transplantation

5.4 Future Trends

5.4.1 Escalating Initiatives from Various Organizations and Governments

5.5 Impact Analysis

6. Corneal Transplantation Market– Europe Analysis

6.1 Europe Corneal transplantation Market Revenue Forecast and Analysis

7. Europe Corneal Transplantation Market Analysis – By Type

7.1 Overview

7.2 Europe Corneal Transplantation Market Revenue Share, By Type (2021 and 2028)

7.3 Penetrating Keratoplasty

7.3.1 Overview

7.3.2 Penetrating Keratoplasty: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Descemet Membrane Endothelial Keratoplasty (DMEK)

7.4.1 Overview

7.4.2 Descemet Membrane Endothelial Keratoplasty (DMEK): Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Descemet Stripping Endothelial Keratoplasty (DSEK)

7.5.1 Overview

7.5.2 Descemet Stripping Endothelial Keratoplasty (DSEK): Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Corneal Limbal Stem Cell Transplant

7.6.1 Overview

7.6.2 Corneal Limbal Stem Cell Transplant: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

8. Europe Corneal Transplantation Market Analysis – By Indication

8.1 Overview

8.2 Europe Corneal transplantation Market Revenue Share, By Indication (2021 and 2028)

8.3 Fuchs’ Dystrophy

8.3.1 Overview

8.3.2 Fuchs’ Dystrophy: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Keratoconus

8.4.1 Overview

8.4.2 Keratoconus: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Fungal Corneal Ulcer

8.5.1 Overview

8.5.2 Fungal Corneal Ulcer: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Keratitis

8.6.1 Overview

8.6.2 Keratitis: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Others

8.7.1 Overview

8.7.2 Others: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Corneal Transplantation Market Analysis – By End User

9.1 Overview

9.2 Europe Corneal Transplantation Market Share, by End User, 2021 and 2028, (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Eye Clinics

9.4.1 Overview

9.4.2 Eye Clinics: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Ambulatory Surgical Centers

9.5.1 Overview

9.5.2 Ambulatory Surgical Centers: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Corneal Transplantation Market – Country Analysis

10.1 Overview

10.1.1 Europe: Corneal transplantation Market, by Country, 2021 & 2028 (%)

10.1.1.1 Germany: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 Germany: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3 Germany: Corneal transplantation Market, by Type- 2019–2028 (US$ Million)

10.1.1.1.4 Germany: Corneal transplantation Market, by Indication- 2019–2028 (US$ Million)

10.1.1.1.5 Germany: Corneal transplantation Market, by End User- 2019–2028 (US$ Million)

10.1.1.2 United Kingdom: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 United Kingdom: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3 United Kingdom: Corneal transplantation Market, by Type- 2019–2028 (US$ Million)

10.1.1.2.4 United Kingdom: Corneal transplantation Market, by Indication- 2019–2028 (US$ Million)

10.1.1.2.5 United Kingdom: Corneal transplantation Market, by End User- 2019–2028 (US$ Million)

10.1.1.3 France: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 France: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3 France: Corneal transplantation Market, by Type- 2019–2028 (US$ Million)

10.1.1.3.4 France: Corneal transplantation Market, by Indication- 2019–2028 (US$ Million)

10.1.1.3.5 France: Corneal transplantation Market, by End User- 2019–2028 (US$ Million)

10.1.1.4 Italy: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Overview

10.1.1.4.2 Italy: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3 Italy: Corneal transplantation Market, by Type- 2019–2028 (US$ Million)

10.1.1.4.4 Italy: Corneal transplantation Market, by Indication- 2019–2028 (US$ Million)

10.1.1.4.5 Italy: Corneal transplantation Market, by End User- 2019–2028 (US$ Million)

10.1.1.5 Spain: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Overview

10.1.1.5.2 Spain: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3 Spain: Corneal transplantation Market, by Type- 2019–2028 (US$ Million)

10.1.1.5.4 Spain: Corneal transplantation Market, by Indication- 2019–2028 (US$ Million)

10.1.1.5.5 Spain: Corneal transplantation Market, by End User- 2019–2028 (US$ Million)

10.1.1.6 Rest of Europe: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Overview

10.1.1.6.2 Rest of Europe: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3 Rest of Europe: Corneal transplantation Market, by Type- 2019–2028 (US$ Million)

10.1.1.6.4 Rest of Europe: Corneal transplantation Market, by Indication- 2019–2028 (US$ Million)

10.1.1.6.5 Rest of Europe: Corneal transplantation Market, by End User- 2019–2028 (US$ Million)

11. Industry Landscape

11.1 Overview

11.2 Organic Developments

11.2.1 Overview

11.3 Inorganic Developments

11.3.1 Overview

12. Company Profiles

12.1 Alcon Inc.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Florida Lions Eye Bank

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Corneat Vision

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Aurolab

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Keramed, Inc.

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Cornea Biosciences, Inc.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Lifeline Scientific, Inc.

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms


LIST OF TABLES

Table 1. Europe Corneal Transplantation Market – Revenue, and Forecast to 2028 (US$ Million)

Table 2. Germany Corneal transplantation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 3. Germany Corneal transplantation Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 4. Germany Corneal transplantation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 5. United Kingdom Corneal transplantation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 6. United Kingdom Corneal transplantation Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 7. United Kingdom Corneal transplantation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 8. France Corneal transplantation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 9. France Corneal transplantation Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 10. France Corneal transplantation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 11. Italy Corneal transplantation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 12. Italy Corneal transplantation Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 13. Italy Corneal transplantation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 14. Spain Corneal transplantation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 15. Spain Corneal transplantation Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 16. Spain Corneal transplantation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 17. Rest of Europe Corneal transplantation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 18. Rest of Europe Corneal transplantation Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 19. Rest of Europe Corneal transplantation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 20. Organic Developments Done by Companies

Table 21. Inorganic Developments Done by Companies

Table 22. Glossary of Terms


LIST OF FIGURES

Figure 1. Europe Corneal Transplantation Market Segmentation

Figure 2. Europe Corneal Transplantation Market, By Country

Figure 3. Europe Corneal transplantation Market Overview

Figure 4. Penetrating Keratoplasty Segment Held the Largest Share of the Market in 2021

Figure 5. Germany Held the Largest Share of the Market in 2021

Figure 6. Europe: PEST Analysis

Figure 7. Experts Opinion

Figure 8. Europe Corneal Transplantation Market Impact Analysis of Driver and Restraints

Figure 9. Europe Corneal Transplantation Market– Revenue Forecast and Analysis to 2028

Figure 10. Europe Corneal Transplantation Market Revenue Share, By Type (2021 and 2028)

Figure 11. Europe Penetrating Keratoplasty: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Europe Descemet Membrane Endothelial Keratoplasty (DMEK): Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Europe Descemet Stripping Endothelial Keratoplasty (DSEK): Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Europe Corneal Limbal Stem Cell Transplant: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Europe Others: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Europe Corneal transplantation Market Revenue Share, By Indication (2021 and 2028)

Figure 17. Europe Fuchs’ Dystrophy: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Europe Keratoconus: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Europe Fungal Corneal Ulcer: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Europe Keratitis: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Europe Others: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Europe Corneal Transplantation Market Share, by End User, 2021 and 2028 (%)

Figure 23. Europe Hospitals: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Europe Eye Clinics: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Europe Ambulatory Surgical Centers: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Europe: Corneal transplantation Market, by Key Country – Revenue (2021) (US$ Million)

Figure 27. Europe: Corneal transplantation Market, by Country, 2021 & 2028 (%)

Figure 28. Germany: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. United Kingdom: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. France: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Italy: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. Spain: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Rest of Europe: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

  1. Alcon Inc.
  2. Aurolab
  3. Cornea Biosciences, Inc.
  4. Corneat Vision
  5. Florida Lions Eye Bank
  6. Keramed, Inc.
  7. Lifeline Scientific, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.